Drug or technology

Combination Therapy

2 developments in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

Latest

Everything in the corpus, newest first.

AUG 26, 2026 · JOURNAL ARTICLE

Biomaterial-based Drug delivery strategies for head and neck cancer: Local delivery, combination therapy, and translational challenges.

International Journal of Pharmaceutics: X

A comprehensive review synthesizing current knowledge on biomaterial-based drug delivery for head and neck cancer, identifying clinical challenges and therapeutic opportunities without presenting original experimental data or clinical trial results.

Expert GuidanceJunxiong Wen Combination Therapy Xiao Cui

Reported

HNSCC and OSCC proportion of HNCapproximately 90%

5-year survival rate for advanced…50–60%

AUG 5, 2026 · JOURNAL ARTICLE

Comparative safety profiles of antibody-drug conjugates: a real-world analysis of monotherapy and combination regimens in solid tumors.

Drug Delivery

Large real-world pharmacovigilance study of 19,697 adverse event reports confirms known structure-toxicity relationships for ADCs, but lacks comparative efficacy data and uses observational methods without prospective controls.

Important Confirmatory EvidenceJie Wang Linjie Fan Combination Therapy

Reported

Sample size (adverse event report…19,697

Number of ADCs analyzed7

Study periodQ1 2004 to Q1 2025